GENOTYPE-BASED IN VITRO-IN VIVO EXTRAPOLATION (IVIVE) OF EFAVIRENZ PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL

被引：0
|
作者：
Xu, C. [1 ]
Quinney, S. [2 ]
Guo, Y. [3 ]
Desta, Z. [1 ]
机构：
[1] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA
[3] Lilly Res Labs, Indianapolis, IN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and Physiologically-Based Pharmacokinetic Modeling of Nanoparticles
    Yang, Raymond S. H.
    Chang, Louis W.
    Yang, Chung Shi
    Lin, Pinpin
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2010, 10 (12) : 8482 - 8490
  • [22] Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition
    Yamazaki, Shinji
    Evers, Raymond
    De Zwart, Loeckie
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (01): : 55 - 67
  • [23] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ACETONE
    KUMAGAI, S
    MATSUNAGA, I
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (05) : 344 - 352
  • [24] In VitroIn Vivo Extrapolation and Bioequivalence Prediction for Immediate-Release Capsules of Cefadroxil Based on a Physiologically-Based Pharmacokinetic ACAT Model
    Rahim, Najia
    Naqvi, Syed Baqir Shyum
    AAPS PHARMSCITECH, 2024, 25 (05)
  • [25] In vitro-in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human
    Alsmadi, Mo'tasem M.
    Alzughoul, Saja B.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2023, 44 (03) : 221 - 244
  • [26] EFFECT OF PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS ON PROPRANOLOL PHARMACOKINETICS USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN HUMANS
    Kiriyama, Akiko
    Honbo, Akino
    Iga, Katsumi
    DRUG METABOLISM REVIEWS, 2007, 39 : 154 - 154
  • [27] Addressing early life sensitivity using physiologically based pharmacokinetic modeling and in vitro to in vivo extrapolation
    Yoon M.
    Clewell H.J., III
    Toxicological Research, 2016, 32 (1) : 15 - 20
  • [28] In vitro-in silico-based probabilistic risk assessment of combined exposure to bisphenol A and its analogues by integrating ToxCast high-throughput in vitro assays with in vitro to in vivo extrapolation (IVIVE) via physiologically based pharmacokinetic (PBPK) modeling
    Lin, Yi-Jun
    Lin, Zhoumeng
    JOURNAL OF HAZARDOUS MATERIALS, 2020, 399 (399)
  • [29] Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs
    Bettonte, Sara
    Berton, Mattia
    Battegay, Manuel
    Stader, Felix
    Marzolini, Catia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (05): : 781 - 794
  • [30] PBTK modeling of selected potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico/in vitro based risk assessments
    Haase, C.
    Fabian, E.
    Ramirez, T.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S47 - S47
12345